Form 4 holding
Director
ANI PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 6,864
- Estimated value
- $622,015
- Report date
- 25 Aug 2025
- Price
- $90.62
- Ownership
- Direct
Matthew J. Leonard
Insider Reports History
- Location
- Portland, ME
- Owner filing signature
- /s/ Matthew J. Leonard, by attorney-in-fact Meredith W. Cook
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
1 identity field
SEC source record
1 source field
SEC evidence
1 source field
Reported holdings for Matthew J. Leonard
Insider Reports Filed by Matthew J. Leonard
4
ANIP
ANI PHARMACEUTICALS INC
- Report period
- 25 Aug 2025
- Transactions
- 1
- Transaction value
- -$229,087
- Accepted by SEC
- 26 Aug 2025, 18:19
- Role
- Director
- Next action
- Open filing details
4
ANIP
ANI PHARMACEUTICALS INC
- Report period
- 18 Aug 2025
- Transactions
- 1
- Transaction value
- -$611,635
- Accepted by SEC
- 18 Aug 2025, 17:23
- Role
- Director
- Next action
- Open filing details
4
ANIP
ANI PHARMACEUTICALS INC
- Report period
- 22 May 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 27 May 2025, 18:19
- Role
- Director
- Next action
- Open filing details
4
ANIP
ANI PHARMACEUTICALS INC
- Report period
- 21 May 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 May 2024, 19:54
- Role
- Director
- Next action
- Open filing details
4
ANIP
ANI PHARMACEUTICALS INC
- Report period
- 21 Aug 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Aug 2023, 20:44
- Role
- Director
- Next action
- Open filing details
3
ANIP
ANI PHARMACEUTICALS INC
- Report period
- 21 Aug 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 23 Aug 2023, 20:39
- Role
- Director
- Next action
- Open filing details